GAMINI WIYATHUNGE: Open Payments
NPI 1265673768 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 18 payments from 8 companies in 2025. Trend: 2023 $592 · 2024 $766 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| Novo Nordisk Inc | 1 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $15 |
Products named: BREZTRI, AIRSUPRA, Ozempic, GEMTESA, MOUNJARO, VOQUEZNA, KRYSTEXXA, GARDASIL 9.
Industry payments across TN — which companies pay providers there.
